Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
June 23rd, 2023
Many upregulated genes stimulate tumor cell migration and invasion, leading to poor prognosis. Determining which genes regulate tumor cell migration and invasion is critical. This protocol presents a method for investigating the effects of the increased expression of a gene on the migration and invasion of tumor cells in real time.
Overview
This protocol demonstrates a method for investigating the effects of gene expression on tumor cell migration and invasion in real time. By combining mRNA transfection with impedance-based measurements, researchers can identify genes that stimulate tumor cell movement, which is crucial for understanding metastasis.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Cancer Research
Background
- Upregulated genes can lead to increased tumor cell migration and invasion.
- Identifying these genes is essential for improving cancer prognosis.
- Real-time monitoring techniques enhance the understanding of tumor dynamics.
- Impedance-based systems provide continuous data on cell behavior.
Purpose of Study
- To investigate the role of specific genes in tumor cell migration and invasion.
- To develop a protocol that combines gene expression analysis with real-time monitoring.
- To identify potential therapeutic targets for inhibiting metastasis.
Methods Used
- Transfection of mRNA to increase gene expression.
- Impedance-based real-time cell analysis system for monitoring migration.
- Quantitative assessment of cell movement in response to gene expression changes.
- Use of plasmid DNA and restriction enzymes for gene manipulation.
Main Results
- Identification of genes that promote tumor cell migration.
- Demonstration of real-time monitoring capabilities for cell behavior.
- Establishment of a method to link gene expression with metastatic potential.
- Potential targets for cancer therapy were highlighted.
Conclusions
- The protocol effectively combines gene expression analysis with real-time monitoring.
- Identifying genes that stimulate migration can inform therapeutic strategies.
- This approach enhances the understanding of cancer metastasis mechanisms.
Frequently Asked Questions
Executive Industry Relevance
Quantitative, real-time measurement of tumor cell migration and invasion following synthetic mRNA transfection enables direct interrogation of gene function in metastatic processes. This approach provides actionable insights for target validation and mechanistic de-risking at the discovery stage, supporting predictive confidence in oncology portfolios. Integration of impedance-based analytics with gene overexpression workflows advances the precision of early-stage decision-making in cancer R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional validation of candidate genes implicated in tumor cell motility and invasion.
- Supports mechanistic de-risking by linking gene expression changes to phenotypic outcomes.
- Facilitates prioritization of targets for anti-metastatic therapeutic strategies.
Screening & Assay Development
- Provides a standardized, quantitative platform for assessing gene-driven changes in cell migration and invasion.
- Delivers reproducible, real-time data suitable for comparative analysis across multiple gene constructs.
- Enables robust assay development for downstream compound screening targeting metastatic pathways.
Translational & Preclinical Research
- Aligns in vitro migration and invasion phenotypes with disease-relevant mechanisms of metastasis.
- Supports continuity from gene function discovery to preclinical model selection and validation.
- Informs risk-adjusted advancement of candidate targets into translational studies.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical research by enabling direct measurement of gene-driven tumor cell behaviors relevant to metastasis.
- Discovery Biology: Quantifies the impact of gene overexpression on tumor cell migration and invasion, clarifying pathway roles.
- Screening: Establishes assay readiness and reproducibility for evaluating gene function and potential inhibitors.
- Analytics: Generates real-time, quantitative impedance data for robust statistical comparison of experimental conditions.
- Translational Research: Connects in vitro findings to disease-relevant metastatic processes, supporting biomarker alignment.
- Enterprise Reuse: Offers a reusable platform for functional genomics and phenotypic screening across oncology programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target selection and reduces mechanistic ambiguity in metastasis research.
- Operational Value: Delivers standardized, scalable, and reproducible workflows for gene function analysis.
- Strategic Value: Improves go/no-go decisions and capital allocation by providing early, quantitative evidence of target relevance.
- Portfolio Impact: Enables risk-adjusted prioritization of anti-metastatic targets for advancement.
Implementation Considerations
- Requires expertise in synthetic mRNA preparation, electroporation, and impedance-based analytics.
- Needs access to real-time cell analysis instrumentation and compatible software infrastructure.
- Demands rigorous cross-team standardization of assay setup and data interpretation.
- May require adaptation for different tumor cell types or ECM conditions based on research focus.
- Dependent on careful handling of cell health and transfection efficiency for reliable outputs.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:56
Synthesis of mRNA
3:57
Extracellular Matrix (ECM) Gel Coating of the Cell Invasion and Migration (CIM) Plates
4:38
Electroporation of the Tumor Cells
5:40
Setting Up the Real‐Time Cell Analyzer, the Program, and the CIM Plates
7:29
Real‐Time Cell Analysis and Data Export
8:23
Results: Tumor Cell Migration and Invasion
10:17
Conclusion
